← Back
$UNCY All transactions

Unicycive Therapeutics, Inc.

D

$ Value

$3.2M

Shares

3,199

Price

$1K

Filed

Aug 26

Insider

Name

Aggarwal Gaurav

Title

CIK

0001551965

Roles

Director

Transaction Details

Transaction Date

2025-08-25

Code

D

Table

Derivative

Ownership

Indirect

Equity Swap

No

Shares After

Footnotes

Each share of Series A-2 Prime Preferred Stock is convertible into a number of shares of Common Stock obtained by dividing the Original Per Share Price ($1,000) by $4.90, subject to blocking provisions. Capitalized terms used but not defined herein shall have the meanings set forth in the Amended and Restated Certificate of Designation of Series A Convertible Voting Preferred Stock, filed as an exhibit to the Issuer's Periodic Report on Form 8-K on March 14, 2024. | Vivo Opportunity Fund Holdings, L.P. is the record holder of the securities. The Reporting Person is a managing member of Vivo Opportunity, LLC, which is the general partner of Vivo Opportunity Fund Holdings, L.P. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes. | The shares of Series A-2 Prime Preferred Stock were issued on March 14, 2024 and do not have an expiration date.

Filing Info

Accession No.

0001213900-25-080808

Form Type

4

Issuer CIK

0001766140

Aggarwal Gaurav's History

Date Ticker Type Value
2025-08-25 UNCY C
2025-08-25 UNCY D $3.2M
2025-07-28 UNCY A $0
2025-05-21 GERN A $0

Other Insiders at UNCY (90d)

No other insider activity at this issuer in the last 90 days.